title: Gene and cell therapy based treatment strategies for inflammatory bowel diseases.
abstract: Inflammatory bowel diseases (IBD) are a group of chronic inflammatory disorders most commonly affecting young adults. Currently available therapies can result in induction and maintenance of remission, but are not curative and have sometimes important side effects. Advances in basic research in IBD have provided new therapeutic opportunities to target the inflammatory process involved. Gene and cell therapy approaches are suitable to prevent inflammation in the gastrointestinal tract and show therefore potential in the treatment of IBD. In this review, we present the current progress in the field of both gene and cell therapy and future prospects in the context of IBD. Regarding gene therapy, we focus on viral vectors and their applications in preclinical models. The focus for cell therapy is on regulatory T lymphocytes and mesenchymal stromal cells, their potential for the treatment of IBD and the progress made in both preclinical models and clinical trials.
authors.affiliation: Department of Research and Development, Amsterdam Molecular Therapeutics BV, 1105 BA Amsterdam, The Netherlands. s.vandermarel@amtbiopharma.com
authors.forename: Sander
authors.initials: S
authors.lastname: van der Marel
authors.forename: Anna
authors.initials: A
authors.lastname: Majowicz
authors.forename: Sander
authors.initials: S
authors.lastname: van Deventer
authors.forename: Harald
authors.initials: H
authors.lastname: Petry
authors.forename: Daniel W
authors.initials: DW
authors.lastname: Hommes
authors.forename: Valerie
authors.initials: V
authors.lastname: Ferreira